Ikarian Capital, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.2 - $2.08 $19,938 - $207,361	-99,693 Reduced 52.49%	90,242 $18,000
Q3 2022 Nov 14, 2022	SELL	$2.55 - $4.42 $161,917 - $280,656	-63,497 Reduced 25.05%	189,935 $839,000
Q2 2022 Aug 12, 2022	SELL	$2.71 - $3.6 $137,475 - $182,624	-50,729 Reduced 16.68%	253,432 $698,000
Q1 2022 May 13, 2022	BUY	$2.92 - $4.19 $42,664 - $61,220	14,611 Added 5.05%	304,161 $1.02 Million
Q3 2021 Nov 15, 2021	SELL	$3.14 - $4.09 $11,461 - $14,928	-3,650 Reduced 1.24%	289,550 $955,000
Q1 2021 May 17, 2021	BUY	$3.46 - $7.88 $1.01 Million - $2.31 Million	293,200 New	293,200 $1.12 Million

10.5M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $69.3M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.